Meeting
2013 ASCO Quality Care Symposium
Improving the care of acute lymphocytic leukemia (ALL) at a large county hospital.
Authors
Meghan Sri Karuturi
The University of Texas MD Anderson Cancer Center, Houston, TX
Meghan Sri Karuturi, Jeffrey Thomas Yorio, Annie Titus, Stephenie Jeanette Pharr, Alyssa G. Rieber
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session B: Practice of Quality and Health Reform
Track
Practice of Quality,Health Reform: Implications for Costs and Quality
Sub Track
Learning from Projects Done in a Health System
Citation
J Clin Oncol 31, 2013 (suppl 31; abstr 213)
Abstract #
213
Poster Bd #
D16
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
A phase 2 study of hyper-CVAD plus ofatumumab as frontline therapy in CD20+ acute lymphoblastic leukemia (ALL): Updated results.
First Author: Abdul Hamid Bazarbachi
Poster
2017 ASCO Annual Meeting
Updated results of a phase I/II study of inotuzumab ozogamicin in combination with low-intensity chemotherapy (mini-hyper-CVD) as frontline therapy for older patients with acute lymphoblastic leukemia.
First Author: Nicholas James Short
Poster
2017 ASCO Annual Meeting
Inotuzumab ozogamicin (IO) combined with mini-hyper-CVD as salvage therapy for patients (pts) with R/R acute lymphoblastic leukemia (ALL).
First Author: Rita Assi
Poster
2014 ASCO Annual Meeting
Inotuzumab ozogamicin (IO) in combination with low-intensity chemotherapy as front-line therapy for older patients (pts) and as salvage therapy for adult with R/R acute lymphoblastic leukemia (ALL).
First Author: Elias Jabbour